Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

SIMPLE SUMMARY: Primary central nervous system lymphoma is a rare disease with limited therapeutic options. A more profound understanding of the molecular mechanisms that underlie this disease has fostered the development of novel therapeutic approaches. Key developments for the treatment of primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirsching, Hans-Georg, Weller, Michael, Balabanov, Stefan, Roth, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234854/
https://www.ncbi.nlm.nih.gov/pubmed/34203062
http://dx.doi.org/10.3390/cancers13123073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234854/
https://www.ncbi.nlm.nih.gov/pubmed/34203062
http://dx.doi.org/10.3390/cancers13123073

Ejemplares similares